NATIONAL HEART CENTRE OF SINGAPORE PTE LTD

A multinational,randomized open-label,parallel-group, active-controlled,two-arm, long-term morbidity and mortality trial involving intensive preventive therapy (high dose renin-angiotensin-aldosterone system inhibitors [RAASi],beta-blockade,sodium-glucoseco-transporter 2